Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 09, 2012 06:42 ET | Source: Genomic Health, Inc.

New Research Shows Genomic Testing Changes Chemotherapy Treatment Decisions in British Columbia Breast Cancer Patients by 30 Per Cent

TORONTO, July 9, 2012 (GLOBE NEWSWIRE) -- Genomic Health, Inc. (Nasdaq:GHDX) today has released the results of the first Oncotype DX breast cancer test treatment decision-impact study from Canada,...